BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 28944551)

  • 1. Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables.
    Burgess S; Zuber V; Valdes-Marquez E; Sun BB; Hopewell JC
    Genet Epidemiol; 2017 Dec; 41(8):714-725. PubMed ID: 28944551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.
    Burgess S; Dudbridge F; Thompson SG
    Stat Med; 2016 May; 35(11):1880-906. PubMed ID: 26661904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical methods for cis-Mendelian randomization with two-sample summary-level data.
    Gkatzionis A; Burgess S; Newcombe PJ
    Genet Epidemiol; 2023 Feb; 47(1):3-25. PubMed ID: 36273411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of allele scores as instrumental variables for Mendelian randomization.
    Burgess S; Thompson SG
    Int J Epidemiol; 2013 Aug; 42(4):1134-44. PubMed ID: 24062299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disentangling the effects of traits with shared clustered genetic predictors using multivariable Mendelian randomization.
    Batool F; Patel A; Gill D; Burgess S
    Genet Epidemiol; 2022 Oct; 46(7):415-429. PubMed ID: 35638254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian randomization analysis with multiple genetic variants using summarized data.
    Burgess S; Butterworth A; Thompson SG
    Genet Epidemiol; 2013 Nov; 37(7):658-65. PubMed ID: 24114802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
    Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
    Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid.
    Burgess S; Zuber V; Gkatzionis A; Foley CN
    Int J Epidemiol; 2018 Aug; 47(4):1242-1254. PubMed ID: 29846613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of instrumental variable estimators for Mendelian randomization.
    Burgess S; Small DS; Thompson SG
    Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of robust Mendelian randomization methods using summary data.
    Slob EAW; Burgess S
    Genet Epidemiol; 2020 Jun; 44(4):313-329. PubMed ID: 32249995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
    Burgess S; Thompson SG
    Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
    Grant AJ; Burgess S
    Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
    Bowden J; Del Greco M F; Minelli C; Davey Smith G; Sheehan NA; Thompson JR
    Int J Epidemiol; 2016 Dec; 45(6):1961-1974. PubMed ID: 27616674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors.
    Burgess S; Butterworth AS; Thompson JR
    J Clin Epidemiol; 2016 Jan; 69():208-16. PubMed ID: 26291580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates.
    Burgess S; Labrecque JA
    Eur J Epidemiol; 2018 Oct; 33(10):947-952. PubMed ID: 30039250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods.
    Cao Y; Rajan SS; Wei P
    Genet Epidemiol; 2016 Dec; 40(8):744-755. PubMed ID: 27813215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constrained instruments and their application to Mendelian randomization with pleiotropy.
    Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
    Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.
    Burgess S; Scott RA; Timpson NJ; Davey Smith G; Thompson SG;
    Eur J Epidemiol; 2015 Jul; 30(7):543-52. PubMed ID: 25773750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.